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Abstract
Stanniocalcin-1 (STC1), a glycoprotein hormone, is believed to be involved in various biological processes such as
inflammation, oxidative responses and cell migration. Riding on these emerging evidences, we hypothesized that STC1 may
participate in the re-epithelialization during wound healing. Re-epithelialization is a critical step that involves keratinocyte
lamellipodia (e-lam) formation, followed by cell migration. In this study, staurosporine (STS) treatment induced human
keratinocyte (HaCaT) e-lam formation on fibronectin matrix and migration via the activation of focal adhesion kinase (FAK),
the surge of intracellular calcium level [Ca
2+]i and the inactivation of Akt. In accompanied with these migratory features, a
time- and dose-dependent increase in STC1 expression was detected. STC1 gene expression was found not the downstream
target of FAK-signaling as illustrated by FAK inhibition using PF573228. The reduction of [Ca
2+]i by BAPTA/AM blocked the
STS-mediated keratinocyte migration and STC1 gene expression. Alternatively the increase of [Ca
2+]i by ionomycin exerted
promotional effect on STS-induced STC1 gene expression. The inhibition of Akt by SH6 and GSK3b by lithium chloride (LiCl)
could respectively induce and inhibit the STS-mediated e-lam formation, cell migration and STC1 gene expression. The STS-
mediated e-lam formation and cell migration were notably hindered or induced respectively by STC1 knockdown or
overexpression. This notion was further supported by the scratched wound assay. Collectively the findings provide the first
evidence that STC1 promotes re-epithelialization in wound healing.
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Introduction
Human stanniocalcin-1 (STC1) is a glycoprotein hormone that
is widely expressed in various tissues [1,2]. Modulation of STC1
expression has been reported in numerous physiological and
pathological processes, such as cell proliferation/apoptosis [3,4,5],
inflammation [6,7], angiogenesis [8,9] and steroidogenesis [10].
Emerging evidences have pointed out the involvement of STC1 in
carcinogenesis [11,12,13,14,15,16,17,18,19]. It is generally be-
lieved that both carcinogenesis and wound healing show similar
biological features in the processes of inflammation and angio-
genesis [20]. At the molecular level, notable similarities in gene
expression between cancers and wounds have been reported [21].
Based on the previous findings of STC1 on carcinogenesis, we
hypothesized that STC1 may take part in the wound healing
process.
Wound healing plays a vital role for the maintenance of the
integrity of the skin and mucosal membranes. In fact, there are
three major skin responses after injury, including inflammation, re-
epithelialization (migration of keratinocytes) and remodeling
(formation of granulation tissues) [22]. To maintain the normal
healing process, the presence of both macrophages and T
lymphocytes at the wound bed is essential [23]. In a cell migration
study, the transendothelial migration of human umbilical vein
endothelial cells was found to be inhibited by STC1 [6]. In
contrast to the inhibitory effect of STC1 on the transendothelial
migration, STC1 exerted a promigratory effect on human ovarian
cancer cells [14]. Another study however reported a selective
modulatory role of STC1 on hepatocyte growth factor-induced
endothelial migration [9]. Riding on the inconclusive role of STC1
on the cell migration process, we are interested in elucidating the
regulation and function of STC1 in keratinocyte migration, a
critical step for tissue repair and wound healing.
Staurosporine (STS) a broad kinase inhibitor confers a useful
tool to study cell migration as STS-induced aggressive phenotypes
have been illustrated in a variety of cell types [24,25,26].
Particularly, treatment of STS in human normal epidermal
keratinocyte cell line HaCaT could sufficiently induce lamellipodia
extension (e-lam) and cell migration [27]. In this study, we
attempted to elucidate the role of STC1 in keratinocyte re-
epithelialization during the wound healing process. Our data have
demonstrated the enhancing effect of STC1 on STS-stimulated e-
lam formation and cell migration via Akt pathway.
Results
Staurosporine induces focal adhesion kinase
phosphorylation, formation of extended lamellipodia on
fibronectin matrix, cell motility and STC1 mRNA
expression
Extended lamellipodia (e-lam) means lamellipodia containing a
growth cone at the tip. The formation of e-lam on fibronectin
matrix and the increase of keratinocyte migration are the two
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adhesion kinase (FAK) autophosphorylation at Tyr-397 is one of
the key molecules in fibronectin-stimulated signaling to stimulate
cell motility [29]. Upon stimulation of the HaCaT cells by STS
for 24 h, the number of e-lam formation on the fibronectin-
coated plate was dose-dependently increased, but wasn’t at the
highest dose of treatment (10 nM) owing to a significant increase
in STS-induced cell death (Fig 1A). By using Boyden Chamber,
STS treatment (5 nM) increased cell motility by 5-fold at 24 h as
compared with the control (Fig.1B). The STS treatment also
stimulated FAK phosphorylation at Tyr-397 (Fig. 1C). Using
FAK inhibitor (PF573228), the degree of keratinocyte migration
in both control and STS treated cells were suppressed (3.64- and
7.11-fold reduction in the Ctrl and STS treatment, respectively,
Fig. 1D). The STS treatment was also able to upregulate STC1
mRNA and protein expressions in a dose-dependent manner
(2.5–10 nM) (Fig. 1E). Intriguingly STS-induced STC1 expres-
sion could not be significantly inhibited by PF573228 c-treatment
(Fig. 1F).
Staurosporine-induced events are mediated by an
increase of intracellular free Ca
2+
By measuring intracellular Ca
2+ [Ca
2+]i using Fura 2-AM, an
increase of [Ca
2+]i was demonstrated in the STS treated cells. The
ratio 340 nm/380 nm was surged immediately after an addition of
5 nM STS, which indicated that STS was able to elevate [Ca
2+]i
in the HaCaT cells (Fig. 2A). When an intracellular calcium
chelator BAPTA/AM, was added into the cells, cell motility was
suppressed by 2.77-fold (Fig. 2B). To ascertain the effect of [Ca
2+]i
on STC1 expression, both BAPTA/AM and the potent calcium
ionophore agent ionomycin, were used to pretreat the cells for 1 h
before STS stimulation. In the absence of STS, STC1 mRNA
showed an 8-fold induction in 1 mM ionomycin treatment. No
noticeable effect was observed in BAPTA/AM alone treatment
(Fig. 2C). In the presence of STS, STC1 mRNA expression was
synergistically enhanced by ionomycin (2.53-fold induction versus
STS alone), but was reduced by 2.52-fold upon BAPTA/AM
pretreatment (Fig. 2C).
Staurosporine-induced events are mediated by Akt-
GSK3b signaling
Koivisto’s group demonstrated that e-lam formation in the
HaCaT cells is regulated by GSK3b-signaling pathway [27]. In
the fact that GSK3b and Akt are tightly coordinated [30], studying
the role of Akt-GSK3b in our model was necessary. Using
pharmacological approaches, LiCl and SH6 were used respec-
tively, to inhibit GSK3b and Akt pathways. The cells were
pretreated with 30 mM LiCl or 10 mM SH6 for 1 h before the
addition of STS. In Fig. 3A, the protein lysates were extracted
after treatment and were probed for both the phosphorylated and
total forms of GSK3b and Akt. Activation of GSK3b was depicted
by the de-phosphorylation of GSK3b (Ser9); whereas the
activation of Akt was indicated by the phosphorylation at
Ser473. Figure 3A showed the inhibitory effects of LiCl and
SH6 on GSK3b and Akt respectively. STS treatment could
significantly suppress Akt phosphorylation but not on GSK3b.
STS elicited e-lam formation was blocked by LiCl (2.25-fold
reduction versus STS alone), but augmented in SH6 pretreatment
(1.8-fold induction versus STS alone) (Fig. 3B). Using the cell
migration assay, STS-mediated migration was suppressed upon
LiCl pretreatment (3.77-fold versus STS alone), but was stimulated
in SH6-pretreated cells (1.37-fold versus STS alone) (Fig. 3C).
Likewise, STS-induced STC1 mRNA expression was inhibited by
3.8-fold and augmented by 2.6-fold (versus STS alone) in LiCl and
SH6 pretreatment, respectively (Fig. 3D).
STC1 knockdown hinders STS-induced extended
lamellipodia and cell migration
We then conducted STC1 knockdown using siRNA technique,
to reveal its role in STS-mediated re-epithelialization. After 48 h
post-transfection of STC1 siRNA in the HaCaT cells, STC1 gene
expression level was remarkably reduced by 6.29-fold as compared
with the NS siRNA-transfected cells (Fig. 4A). Strikingly in STC1
siRNA-transfected cells, 2.13- and 1.98-fold reduction in STS-
mediated cell migration (Fig. 4B) and e-lam formation (Fig. 4C)
were detected. In the STS and LiCl/SH6 cotreatment, the
knockdown STC1 was found to inhibit cell migration (Fig. 4D).
The synergistic effect of STS/SH6 on the increase of e-lam
formation was also significantly reduced in the STC1 siRNA
transfected cells (Fig. 4E).
STC1 overexpression promotes STS-induced extended
lamellipodia and cell migration
In addition to STC1 knockdown, the effects of transient
overexpression of STC1 on STS-induced e-lam and cell migration
were investigated. In Fig. 5A, the overexpression of V5-tagged
STC1 in the HaCaT cells was confirmed using V5 antibody. In
the presence of STS, the overexpression of STC1 (STC1/pLenti)
in STS-treated cells could further suppress Akt activation as
compared with the empty vector transfected cells (pLenti). The
overexpression however had no significant effect on the GSK3b
activity. In the unstimulated cells, the overexpression of STC1
alone was not able to promote e-lam formation (Fig. 5B) and cell
migration (Fig. 5C). However in the STS-stimulated cells, STC1
overexpression was able to augment both e-lam formation (1.9-
fold) and cell migration (2.79-fold). Moreover STC1 overexpres-
sion was not able to avert the inhibitory effect of LiCl on e-lam
formation and cell migration (data not shown). Nevertheless the
pro-migratory effect of STC1 was further supported by the data of
the scratched wound healing assay. Using the conditioned medium
(CM) prepared from the established tetracycline-inducible STC1-
expressing CNE2 cells, the scratched wound was found to be
rapidly closed in the HaCaT cells maintained in the conditioned
medium containing overexpressed STC1 protein (CM-STC1)
(Fig. 5D). Both cell count and MTT assays suggested that there
was no significant difference in the rate of cell proliferation
between the HaCaT cells incubated in the condition media with
(CM-STC1) or without overexpressed STC1 (CM-Ctrl) (data not
shown).
Discussion
STC1 has been reported to be involved in a variety of
physiological/pathological processes including inflammation, an-
giogenesis and oxidative stress [6,7,9,31,32,33,34,35,36,37,38,39],
and these findings prompted us to investigate whether STC1 plays
role in wound healing process. Re-epithelialization is a critical step
for wound healing process that involves migration and prolifer-
ation of keratinocytes [28]. Keratinocyte migration comprises of a
repeated cycle of protrusion, adhesion, cell contraction, and rear
release [40]. Protrusion, the formation of e-lam, is a key step for
the establishment of cell polarity to initiate migration. Therefore in
this study, we attempted to investigate the role of STC1 on the
process of re-epithelialization. Using the human keratinocyte
model HaCaT cells, we were able to illustrate the involvement of
STC1 in re-epithelialization especially in e-lam formation and
keratinocyte migration. The process of re-epithelialization and
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PLoS ONE | www.plosone.org 2 November 2011 | Volume 6 | Issue 11 | e27094Figure 1. STS induces keratinocyte migration and STC1 mRNA expression. (A) In the cell spreading assay, e-lam formation on fibronectin-
coated plate was induced by increasing doses of STS treatment (0, 2.5, 5, 10 nM) for 24 h. The cell images were captured under magnification of 200x
(top). (B) Cell migration through the transwell was induced by 5 nM STS for 24 h and the cell images were captured under 100x magnification (top).
(C) Western blot analysis demonstrated the increase of FAK phosphorylation (pY397) upon 5 nM STS treatment from 10–360 s. (D) Cell migration was
increased upon STS treatment at 24 h, but was blocked by 2 mM PF573228. Cell images were captured under 100x magnification (top). (E) STC1 mRNA
and protein expressions were induced by increasing doses of STS treatment (0, 2.5, 5, 10 nM). (F) STS-induced STC1 mRNA expression was not
significantly abolished by PF573228 at 24 h. Asterisks (***) denote p,0.0001, (**) denote p,0.005 and (*) denote p,0.01 as compared to the
respective control treatment.
doi:10.1371/journal.pone.0027094.g001
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2+ and Akt-
GSK3b signaling.
In this model, keratinocyte e-lam formation and migration were
found to be associated with [Ca
2+]i elevation and focal adhesion
kinase (FAK) activation. This agrees with the recent findings that
an increase of [Ca
2+]i was detected in STS stimulation of cell
migration [41,42]. In particularly, STS-induced Ca
2+ mobilization
is necessary for the activation of calcium-dependent enzymes in
the wound sites [43] to initiate cell motility [42] and to facilitate
rear-end detachment [44]. In accompanied with the activation of
FAK and Ca
2+-signaling, STC1 mRNA expression was found to be
upregulated. To decipher the regulatory role of FAK/Ca
2+-
signaling on the induction of STC1 expression, the inhibitors and/
or the activator of the respective pathway were assessed.
Surprisingly, STS-induced STC1 expression was found to be
independent of FAK signaling, although the possible regulatory
relationship was suggested [9]. Moreover the positive regulatory
role of Ca
2+ on STC1 expression was found to be consistent in
respect to the conserved biological functions of STC1 on calcium
regulation in vertebrates [6,45,46,47]. In this study the involve-
ment of STC1 on Ca
2+-stimulated keratinocyte migration is firstly
revealed. In addition to Ca
2+-signaling, the pro-migratory effect of
STC1 in the STS-treated cells was, at least in part via the
suppression of Akt pathway. Akt signaling involves in a wide range
of cellular processes such as proliferation, differentiation, migra-
tion and invasion [48]. Using a pharmacological approach, both
re-epithelialization process and STC1 expression were augmented
in response to Akt inhibition, but vice versa under GSK3b
inhibition. The data are consistent with other study in which
Akt-mediated GSK3b inhibition showed an abrogate effect on cell
migration in intestinal epithelium cells [49]. Intriguingly STS-
induced STC1 gene expression was accompanied with Akt
inhibition, but had no noticeable effect on the activation of
GSK3b. The data imply that other downstream targets of Akt
pathway, like mTOR, FOXO, IkB kinase (IKK) and Mdm2 [48]
might also be involved in STC1 gene regulation. For instance,
activation of Akt could increase NF-kB activity via phosphoryla-
tion of IKK [50], while the negative effect of NF-kB on STC1
expression was reported in the mouse neuroblastoma cell model
[51]. In addition, Akt could inhibit p53 via phosphorylation of
Mdm2 [52], wherein p53 could stimulate STC1 expression in
human nasopharyngeal cancer cells [3].
In the STC1 knockdown and overexpression experiments, the
pro-migratory effects of STC1 on STS-induced cells were
demonstrated. However STC1 overexpression in the un-stimulat-
ed cells failed to induce e-lam formation and cell migration. In
considering the inconclusive observations on the role of STC1 in
cell migration process [6,9,14], our data imply that STC1 may not
be a key regulator for or against this process. The particular role of
STC1 is probably controlled in cells under different settings that
regulate the pro- or anti-migratory process. From the results of the
STS and LiCl/SH6 co-treatment in the STC1 siRNA transfected
Figure 2. STS-induced migration is mediated by intracellular Ca
2+ influx. (A) STS treatment increased [Ca
2+]i as measured using Ca
2+
detection dye, Fura 2-AM. (B) The number of migrated cells was significantly reduced by 10 mM BAPTA/AM at 24 h (vs Ctrl) and the cell images were
captured under 100x magnification (top). (C) STS-induced STC1 mRNA was further induced by 1 mM ionomycin but was downregulated by 10 mM
BAPTA/AM at 24 h of the cotreatments. Asterisks (*) denote p,0.05 as compared to the Ctrl.
doi:10.1371/journal.pone.0027094.g002
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PLoS ONE | www.plosone.org 4 November 2011 | Volume 6 | Issue 11 | e27094Figure 3. Akt-GSK3b signaling mediates the keratinocyte migration process. (A) The inhibitory effects of 30 mM LiCl and 10 mM SH6 on
GSK3b and Akt-signaling respectively, were determined by probing the phosphorylated and total forms of GSK3b and Akt. The band intensities were
measured and the ratios of phosphorylated/total form were plotted. Bars with the same letter are not significantly different according to the resultso f
one-way ANOVA followed by Duncan’s multiple range tests (p,0.05). STS-induced (B) e-lam formation and (C) cell migration were suppressed by LiCl
but were induced by SH6. The cell images were captured under 200x and 100x magnification for e-lam formation and cell migration, respectively
(top). (D) STS-induced STC1 mRNA expression was inhibited by LiCl, but was increased by SH6 (vs STS alone). Asterisks (*) denote p,0.05 as compared
to their corresponding control.
doi:10.1371/journal.pone.0027094.g003
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PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27094Figure 4. STC1 knockdown hinders STS-mediated re-epithelialization process. (A) After the transfection of STC1 siRNA for 48 h, the
knockdown efficiency was examined by real-time PCR. In STC1 siRNA-transfected cells, STS-induced (B) cell migration and (C) e-lam formation on the
fibronectin-coated plates were significantly reduced as compared to the NS siRNA-transfected cells. The cell images were captured for e-lam
formation (200x magnification) and cell migration (100x magnification) (top). Under the STS+LiCl or STS+SH6 cotreatment, (D) the number of
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PLoS ONE | www.plosone.org 6 November 2011 | Volume 6 | Issue 11 | e27094cells, the data support the notion that STC1 is negatively regulated
by Akt-signaling. Consistently the STC1 overexpression experi-
ments illustrate the negative regulatory role of STC1 on Akt
pathway. Retrospectively the activation of GSK3b signaling could
stimulate STC1 expression and enhance the pro-migratory
process.
In conclusion, STS treatment stimulated the transient increase
in FAK phosphorylation and [Ca
2+]i which inhibited Akt signaling
pathway, to initiate re-epithelialization in the HaCaT cells. The
activation of GSK3b and some other Akt-related signaling
molecules stimulate STC1 expression and facilitate keratinocyte
migration. Using both knockdown and overexpression approaches,
the pro-migratory role of STC1 in STS-induced HaCaT cells are
confirmed. Our data warrant further investigation on the
regulation and function of STC1 in the tissue repair and wound
healing process.
Materials and Methods
RNA and Protein Extraction, Real-time PCR and Western
blotting
Total RNA was extracted by TRIZOL according to the
manufacturer’s instructions (Invitrogen), and subjected to DNase I
digestion using TURBO DNAfree (Ambion) to remove any
genomic DNA contamination. Reverse transcription was carried
out using HC RNA-cDNA Master Mix (Applied Biosystems). Real
time-PCR was performed using Fast SYBR Green Master Mix
(Applied Biosystems). The primer sequences for STC1 and b-actin
were as followed: STC1 forward 59-TGAGGCGGAGCAGA
ATGACT-39 and reverse 59-CAGGTGGAGTTTTCCAGG-
CAT-39, and b-actin forward 59-GACTACCTCATGAA-
GATCCTCACC-39 and reverse 59-TCTCCTTAA TGTCACG-
CACGATT-39. The amplification cycles were 95uC for 1 min,
followed by 40 cycles of 95uC for 10 s, 56uC for 10 s and 72uC for
30 s using the ABI StepOne Real-time PCR System (Applied
Biosystems).
For western blotting, protein lysates were extracted from the
cells using RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM
NaCl, 2 mM EDTA, 1% NP-40, 0.1% SDS) and the protein
concentrations were determined by DC protein assay kit II (Bio-
Rad). The protein lysates were resolved by SDS-PAGE and were
blotted as described previously [34]. The blotting was conducted
using mouse anti-V5 (Invitrogen), anti-human STC1 (R&D),
human p-FAK (pY397) (BD Biosciences), rabbit anti-human p-
GSK3b (Ser9), anti-human total GSK3b, anti-human p-Akt
(Ser473), anti-human total Akt (Cell Signaling), and anti-human
actin serum (Sigma). Protein bands were visualized by enhanced
chemiluminescence system (WESTSAVE Up, LabFrontier).
Cell culture
Human normal epidermal keratinocyte cell line HaCaT was
purchased from ATCC. HaCaT is a spontaneously immortalized
keratinocyte cell line, which maintains most of properties of
normal epidermal keratinocytes [53]. The cells were cultured in
Dulbecco’s modified Eagle’s medium (low glucose) (Invitrogen)
supplemented with antibiotics (50 U/ml penicillin and 50 mg/ml
streptomycin) (Invitrogen) and 10% heat-inactivated fetal bovine
serum (FBS) (HyCloneH, Perbio) and were seeded overnight before
treatment or transfection. Human nasopharyngeal carcinoma cell
line CNE2 was a gift from Prof. NK Mak, Hong Kong Baptist
University, Hong Kong. The CNE cells were cultured in RPMI
1640 medium (Invitrogen) supplemented with antibiotics (50 U/
ml penicillin and 50 mg/ml streptomycin) and 10% FBS. Human
embryonic kidney cell line HEK293FT (Invitrogen) was cultured
in Dulbecco’s modified Eagle’s medium (high glucose) (Invitrogen)
supplemented with antibiotics (50 U/ml penicillin and 50 mg/ml
streptomycin), 10% FBS, 6 mM L-glutamine (Sigma), 1 mM
sodium pyruvate (Sigma). The drugs, staurosporine (STS),
BAPTA/AM, ionomycin and SH6 were purchased from Calbio-
chem, and lithium chloride (LiCl) was purchased from Sigma-
Aldrich, and PF573228 was purchased from Torcis. In the study of
the drugs mediated events following STS treatment, the cells were
pretreated with the drugs for 1 h before the addition of STS.
Small interfering RNA (siRNA) transfection
ON-TARGETplus SMARTpool targeting human STC1 (STC1
siRNA) and a non-targeting control (NS siRNA) were purchased
from Dharmacon. The target sequences of STC1 siRNA were: 59-
AAACGCACAUCCCAUGAGA-39;5 9-GGGAAAAGCAUUC-
GUCAAA-39;5 9-GUACAGCGCUGCUAAAUUU-39 and 59-
CAACAGAUACUAUAACAGA-39. The target sequence of NS
siRNA was 59-GGCUACGUCCAGGAGCGCA-39. Briefly, Ha-
CaT cells (7610
4) were seeded in the 12-well plates overnight.
One hundred ml of 50 nM siRNA and 1.5 ml of siLentFect (Bio-
Rad) complex was mixed and was added into the cells according to
the manufacturer’s instruction. The efficiency of STC1 knock-
down was examined at 48 h of post-transfection using real-time
PCR.
Overexpression of STC1
Construction of pLenti6.3/TO/V5-DEST-STC1 plasmid.
A human STC1 cDNA encoding wild-type full-length without the
stop codon was amplified by PCR and was cloned into
pENTR
TM/SD/D-TOPO (Invitrogen) according to the manufac-
turer’s instruction. Then the STC1 insert was transferred from
pENTR
TM/SD/D-TOPO into an expression vector pLenti6.3/
TO/V5/-DEST (Invitrogen) using GatewayH LR Clonase
TM II
Plus Enzyme Mix (Invitrogen).
Transient transfection of STC1 in the HaCaT
cells. pLenti6.3/TO/V5-DEST-STC1 (STC1/pLenti) or
pLenti6.3/TO/V5 (pLenti) was transfected into the HaCaT cells
using Lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instruction. Protein expression level of STC1 was
confirmed at 24 h of post-transfection using western blot.
Lentivirus overexpression of STC1 in the CNE2
cells. Tetracycline-inducible STC1 overexpression in the
CNE2 cells was established using ViraPower
TM HiPerform
TM
T-REx
TM GatewayH Vector Kit (Invitrogen) and was conducted
as described in the manufacturer’s instruction. Briefly, 80%
confluence of HEK293FT cells were seeded on 100 mm cell
culture dishes overnight. Lentivirus was produced by the
cotransfection of ViraPower
TM Packaging mix (Invitrogen) with
either the pLenti6.3/TO/V5-DEST-STC1 (STC1/pLenti) for
STC1 expression or pLenti3.3/TR (Invitrogen) for tetracycline
(Tet) repressor expression using Lipofectamine 2000. Viral
supernatants were harvested at 48 h after transfection. The viral
migrated cells and (E) e-lam formation on fibronectin-coated plate were compared between the STC1 siRNA-transfected cells and the NS siRNA-
transfected cells. The knockdown of STC1 was found to inhibit cell migration induced by the STS + LiCl/SH6 cotreatments. The synergistic effect of
STS/SH6 on the increase of e-lam formation was significantly reduced in the STC1 siRNA transfected cells. Asterisks (**) denote p,0.01 and (*) denote
p,0.05 as compared to their corresponding NS siRNA-transfected cells.
doi:10.1371/journal.pone.0027094.g004
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27094Figure 5. STC1 enhances STS-mediated re-epithelialization process. (A) After transient transfection of V5-tagged STC1/pLenti (STC1/pLenti)
and empty vector control (pLenti) into the HaCaT for 24 h, the cells were treated with 5 nM STS for 24 h and the protein expression levels of V5,
GSK3b and Akt were determined using western blotting. The band intensities were measured and the ratios of the respective phosphorylated/total
proteins were plotted. STC1 overexpression was found to have synergistic effect on STS-inhibited phosphorylation of Akt. STS-induced (B) e-lam
formation on fibronectin-coated plate and (C) cell migration were synergistically induced by the transient overexpression of STC1 (vs STS-treated
pLenti). The cell images were captured for e-lam formation (200x magnification) and cell migration (100x magnification) (top). (D) In the scratched
wound healing assay, the scratched wound was closed significantly more rapidly in the cells maintained in the conditioned medium (CM) containing
overexpressed STC1 protein (CM-STC1) than the control medium (CM Ctrl). The cell images were captured under 100x magnification. The levels of
STC1 proteins in the conditioned media (CM-Ctrl and CM-STC1) were determined from day1 to day3 using western blotting. (top); CM-Ctrl depicts as
C and CM-STC1 depicts as T. Asterisks (**) denote p,0.01 and (*) denote p,0.05 as compared to STS-treated pLenti-transfected cells.
doi:10.1371/journal.pone.0027094.g005
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cells (1610
5) were seeded in 6-well plates overnight, and were then
transduced with 1 ml of pLenti3.3/TR lentiviral particles with
6 mg/ml of polybreneH (Sigma). After 24 h of incubation, the
medium containing pLenti3.3/TR lentiviral particles was
removed and was replaced by 1 ml of STC1/pLenti lentiviral
particles with 6 mg/ml of polybreneH and was incubated for
another 24 h. In brief, the stable colonies of CNE2 cells that
expressed STC1 and Tet repressor were selected in RPMI 1640
medium containing 4 mg/ml blasticidin (Invitrogen) and 600 mg/
ml geneticin (Sigma). STC1 overexpression in CNE2 cells was
induced by an addition of 1 mg/ml of tetracycline (Invitrogen) for
24 h. The expression level of STC1 protein in the conditioned
media (CM) was checked by western blotting.
Boyden chamber-based cell migration assay
Cell migration was performed using 24-well Transwell inserts
with 8 mm pore size membrane (Costar, Corning). HaCaT cells
were trypsinized and were washed with serum-free medium twice.
Then, the cells (6610
4) were seeded into the upper chamber of the
insert. The complete medium as a chemo-attractant, was added
into the lower chamber. After 24 h incubation at 37uC, the cells
on the top of the membrane were removed by cotton swabs and
the cells on the bottom (migrated cells) were rinsed with PBS, fixed
in methanol followed by staining with 0.5% crystal violet (Farco
Chemical Supplies). The total number of migrated cells was
counted under microscope and cell morphology was captured at
1006magnification.
Scratch wound healing assay
Wound healing assay was conducted using 6-well culture plates.
The HaCaT cells were seeded to a confluent density and were
wounded by dragging a plastic pipette tip. The cells were then
incubated in the conditioned media with or without STC1
overexpressed protein. Cell images were captured from day 1 to
day 3 under an inverted microscope (1006 magnification). To
elucidate if the restoration of the scratch wound was due to an
increase of proliferative rate of the cells, cell counting and MTT
assays were conducted. HaCaT cells (5610
4) were seeded in 12-
well plates overnight, in the conditioned medium with or without
STC1 overexpressed protein. On day1–3, the cells were
trypsinized and were mixed 1:1 with trypan blue solution. The
number of cell was counted using hemocytometer using a
microscope (AE31, Motic). Cell viability was also assessed by
MTT [3-(4,5-dimethyl-thiazol-2-yl)-2,5- diphenyltetrazolium bro-
mide] (Sigma-Aldrich) assay. HaCaT cells (8610
3) were seeded in
96-well plates in the conditioned medium with or without STC1
overexpressed protein for 3 days. On each day, the cells were
incubated with 500 mg/ml of MTT at 37uC for 4 h. The medium
was then aspirated, followed by resuspension in 100 ml of DMSO.
The absorbance was measured at 540 nm by a plate reader
(ELx800, BioTek).
Cell spreading assay
Before cell seeding, 24-well culture plates were coated with
5 mg/ml of fibronectin (Millipore) and were kept at 4uC overnight,
followed by blocking with 1% bovine serum albumin (BSA, USB)
for 30 min at room temperature. Then, HaCaT cells (2610
4) cells
were seeded and allowed to spread for 24 h. The cells were then
fixed with Cytoskelfix
TM Cell Fixative (Cytoskeleton) at 220uC for
10 min followed by staining in 0.5% of crystal violet. The cell
images were captured at 200x magnification in at least 5 random
fields in each well and the percentage of cells spread with e-lam
was counted.
Intracellular fluorescence measurement of calcium
Intracellular calcium level was measured by using a dual-
excitation fluorescence photomultiplier system (Nikon). HaCaT
cells (1610
5) were seeded on sterilized glass coverslips in 6-well
culture plates overnight, followed by incubation in 1 mM of Fura
2-AM dye (Calbiochem) at 37uC for 2 h. The coverslip was
mounted in a custom-designed device and was placed on the stage
of the microscope. Fura 2-AM fluorescence (emission: 510 nm)
following alternate excitation at 340 and 380 nm was continuously
monitored before and after the addition of 5 nM STS. The
fluorescence ratio (340/380 nm) and images were acquired using
MetaFluor software (Universal Imaging).
Statistical analysis
All data were analyzed by a Student’s t-test or one-way analysis
of variance (ANOVA) followed by Duncan’s multiple range test.
All data are represented as statistical means 6 SD. A p value
,0.05 was considered statistically significant. All experiments were
performed in triplicates at least.
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